Image
Roadlink International Trading Limited Successfully Tests Driverless Car in Shenzhen
18 nov. 2022 10h00 HE | Roadlink International Trading Limited
HONG KONG, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Roadlink International Trading Limited said that the testing in Shenzhen over the past six months included a "driverless car safely navigating roads...
Namecoach logo600x314.png
Namecoach Lands $8 Million Series A to Advance DEI and End Name Butchering in the Workplace
17 nov. 2022 09h25 HE | Namecoach
PALO ALTO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Namecoach, the technology company solving name mispronunciation and gender communication in critical settings, has secured a Series A funding...
EVAXION_BLACK_RGB.jpg
Evaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02
17 nov. 2022 06h59 HE | Evaxion Biotech
COPENHAGEN, Denmark, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
TIP_link_300x300.jpg
Intelligent Virtual Assistant Market Growth Worth $47.57 Bn Globally by 2028, Driven by High Adoption of Chatbots – Exclusive Report by The Insight Partners
16 nov. 2022 08h47 HE | The Insight Partners
New York, Nov. 16, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Intelligent Virtual Assistant Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Service, Technology...
Symbotic-horizontal-full-color.png
Symbotic Announces Date for Reporting Fourth Quarter and Fiscal Year 2022 Financial Results
15 nov. 2022 16h30 HE | Symbotic Inc.
WILMINGTON, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced it will release its fourth...
EVAXION_BLACK_RGB.jpg
Evaxion CEO comments on strategic focus
10 nov. 2022 04h10 HE | Evaxion Biotech
COPENHAGEN, Denmark, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
Omniq.png
OMNIQ Named a Total Solution Partner for One of The Largest Global Leaders in Enterprise Asset Intelligence for Robotics Supply Chain Management.
17 oct. 2022 08h45 HE | OMNIQ Corp.
SALT LAKE CITY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced...
EVAXION_BLACK_RGB.jpg
Evaxion welcomes Per Norlén as new CEO.
05 oct. 2022 08h32 HE | Evaxion Biotech
COPENHAGEN, Denmark, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...
Omniq.png
omniQ CEO to present at Rosenblatt Securities 2nd Annual Technology Summit: The Age of AI Scaling.
19 août 2022 08h45 HE | OMNIQ Corp.
SALT LAKE CITY, Aug. 19, 2022 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced...
Accuro Epidural Guidance Device Demonstrated Superior for Spinal Anesthesia Administration Compared to Palpation & Conventional Ultrasound in a Parturient With Extreme Obesity
16 août 2022 06h00 HE | RIVANNA (rivannamedical.com)
CHARLOTTESVILLE, Va., Aug. 16, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, announced the results of a clinical case study demonstrating that Accuro...